Full evolutionary journey of hospital superbug mapped for the first time

  Hinxton, Cambridgeshire, UK (March 9, 2021) — Modern hospitals and antibiotic treatment alone did not create all the antibiotic resistant strains of bacteria we see today. Instead, selection pressures from before widespread use of antibiotics influenced some of them to develop, new research has discovered. By using analytical and sequencing technology that has only
WEITERLESEN »

A new predictive model helps identify those at risk for severe COVID-19

Buck scientists analyze data from 3 million people using a smartphone app in the United Kingdom   Novato, CA, USA (March 9, 2021) — Researchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use of immunosuppressant medication, use of a
WEITERLESEN »

Study reveals new hope for men with common urinary issues

  Leawood, KS, USA (March 9, 2021) — A new systematic review of evidence recommends the use of behavioral self-management treatments for common urinary issues experienced by upwards of 70 percent of older men. Common symptoms include trouble urinating, increased frequency and incontinence. These symptoms can have a substantial negative impact on sleep, social functioning
WEITERLESEN »

Treating incontinence in primary care: A doctor versus mobile app trial

Treating incontinence in primary care: A doctor versus mobile app trial App-based treatment in primary care for urinary incontinence: A pragmatic, randomized controlled trial   Leawood, KS, USA (March 9, 2021) — A mobile app designed to help women manage urinary incontinence was as effective as usual, in-person treatment of incontinence in primary care, according
WEITERLESEN »

Targeted immunotherapy could boost radiotherapy response

  London, UK (March 7, 2021) — Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a new study suggests. Researchers believe that manipulating bowel cancers based on their ‘immune landscape’ could unlock new ways to treat resistant tumours. Cancers can evolve resistance to radiotherapy just as they do with
WEITERLESEN »

After old age, intellectual disability is greatest risk factor for death from COVID-19

A study of national data shows the devastating impact the pandemic has had on those with intellectual disabilities and their caregivers.   PHILADELPHIA, USA (March 5, 2021) — Intellectual disability puts individuals at higher risk of dying earlier in life than the general population, for a variety of medical and institutional reasons. A new study
WEITERLESEN »

New Corona test developed

Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples   Leipzig, Germany (march 5, 2021) — Quantitative real-time polymerase chain reaction (qPCR) is the most widely used diagnostic method to detect RNA viruses such as SARS-CoV-2. However, it requires expensive laboratory equipment and global shortages
WEITERLESEN »

Smoking cessation drug may treat Parkinson’s in women

Texas A&M researchers have found that that cytisine can reduce dopamine neuron loss, providing a protective effect against the neurodegenerative disorder.   (March 4, 2021) — Texas A&M University College of Medicine ressearchers have recently discovered that cytisine — a smoking cessation drug commonly used in Europe — reduces the loss of dopamine neurons in
WEITERLESEN »

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021

  Six new medicines recommended for approval Amsterdam, The Netherlands (February 26, 2021) — EMA’s human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting. The Committee recommended granting a marketing authorisation for Evrysdi* (risdiplam), the first treatment that can be given orally to patients with certain types of spinal muscular
WEITERLESEN »

Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19

Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19   Solna, Sweden (February 15, 2021) — This technical report reviews the evidence that has been accumulated since the emergence of COVID-19, in addition to what has existed on this topic prior to the pandemic, and updates the ECDC opinion
WEITERLESEN »

Difficulties to care for ICU patients caused by COVID-19

  Seville, Espagna (February 10, 2021) — Researchers from the University of Seville’s Nursing Department, with the collaboration of professionals from the ICU at Virgen Macarena University Hospital in Seville, have analysed the key factors in caring for critical COVID-19 patients during the first wave of the pandemic. Their study concludes that nursing care was
WEITERLESEN »

Virtual post-sepsis recovery program may also help recovering COVID-19 patients

  New York, NY, USA (Feb. 10, 2021) — A new paper published online in the Annals of the American Thoracic Society describes a “virtual” recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses. In “Translating Post-Sepsis Care to Post-COVID Care: The Case for a Virtual Recovery
WEITERLESEN »

‘Sleep hygiene’ should be integrated into epilepsy diagnosis and management

  Children with epilepsy sleep poorly compared to healthy children, and are more likely to experience disruptions such as night terrors, sleep walking or sleep disordered breathing, according to a new study. A team at the University of Birmingham’s Centre for Human Brain Health analysed 19 published studies on sleep and epilepsy in children and
WEITERLESEN »

Case Western Reserve-led team finds that people with dementia at higher risk for COVID-19

  CLEVELAND, Ohio, USA (Feb. 9, 2021) — A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19–and the risk was higher still for African Americans with dementia. Reviewing electronic health records of 61.9 million adults in the United States, researchers found the
WEITERLESEN »

Cancer leading cause of death among people with diabetes

  London, UK (February 4, 2021) — This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The Lancet Diabetes & Endocrinology. Thursday Feb 4th is World Cancer Day. The research, funded by the Wellcome Trust, reveals that between
WEITERLESEN »

Study finds recommended ICU sedatives equally safe, effective

  Nashville, Tennessee, USA (February 2, 2021) — Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia. A study published today in the New England Journal of Medicine provides the most definitive evidence to date that,
WEITERLESEN »

Lack of ICU beds tied to thousands of excess COVID-19 deaths, Yale study finds

  New Haven, Conn., USA (February 2, 2021) — A new study by Yale researchers found a significant association between the availability of hospital resources — particularly ICU beds — and patient mortality during the early weeks of the COVID-19 pandemic. This was especially true at hospitals in the northeastern U.S. which were hardest hit
WEITERLESEN »

Guidelines for extracorporeal cardiopulmonary resuscitation in children and adults: New ELSO statements in ASAIO Journal

  (February 1, 2021) — Extracorporeal cardiopulmonary resuscitation (ECPR) is a potentially lifesaving treatment for patients in cardiac arrest when the circulation can’t be restored by conventional CPR. New guidelines for ECPR in adults and children, developed by the Extracorporeal Life Support Organization (ELSO), are presented by the ASAIO Journal, official journal of the American
WEITERLESEN »

Prostate drug associated with lower risk of Parkinson’s disease

  Iowa City, Iowa, USA (February 1, 2021) — Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson’s disease, according to a large observational study led by researchers at the University of Iowa, with colleagues in Denmark and China. The findings, published Feb. 1 in
WEITERLESEN »

Genetic screening before prescribing could benefit millions

  Norwich, UK (January 29, 2021) — Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University (Netherlands). Researchers looked through 2019 NHS dispensing data across the UK to see how
WEITERLESEN »

Metformin may affect risk of breast cancer in women with type 2 diabetes

  (January 28, 2021) — A study of 44,541 women has found that there appears to be no association between type 2 diabetes and developing breast cancer overall. This may be because most women in the study with type 2 diabetes were taking metformin, a medication widely used to treat type 2 diabetes, whose actions
WEITERLESEN »

Heparin targets coronavirus spike protein, research shows

Common anticoagulant drug could be repurposed for Covid-19 treatment   Liverpool, UK (January 28, 2021) — An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus’ ability to attach
WEITERLESEN »

How coronavirus damages lung cells within mere hours

Multipronged BU research team finds 18 FDA-approved drugs that could halt coronavirus infection earlier   Boston, Massachusetts; USA (January 28, 2021) — What if scientists knew exactly what impact the SARS-CoV-2 virus had inside our lung cells, within the first few hours of being infected? Could they use that information to find drugs that would
WEITERLESEN »

Hypertension symptoms in women often mistaken for menopause

  Sophia Antipolis, France (January 27, 2021) —  Pregnancy complications and early menopause increase women’s future risk of heart disease. Cardiologists, gynaecologists and endocrinologists recommend how to help middle-aged women prevent later heart problems in a European Society of Cardiology (ESC) consensus document published today in European Heart Journal, a journal of the ESC.1 “Physicians
WEITERLESEN »

90-day vaginal ring shows promise as method for preventing both HIV and pregnancy

Results of second early phase study of the ring containing dapivirine and a contraceptive are encouraging but also indicate a need for reformulation   PITTSBURGH (26 January 2021) — A vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel delivered sustained levels of each drug when used continuously for 90 days –
WEITERLESEN »

Research shows people with high omega-3 index less likely to die from COVID-19

Pilot study shows positive outcomes for those suffering from COVID-19   Sioux Falls, South Dakota, USA (January 26, 2021) — Researchers with the Fatty Acid Research Institute (FARI) and collaborators at Cedars-Sinai Medical Center in Los Angeles and in Orange County, CA, have published the first direct evidence that higher omega-3 blood levels may reduce
WEITERLESEN »

Over half of cannabis users with Parkinson’s disease report clinical benefits

A survey in Germany found over 8% of patients with Parkinson’s disease are using cannabis products and more than half experienced beneficial clinical effects, reports the Journal of Parkinson’s Disease   Amsterdam, NL (January 26, 2021) — With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use
WEITERLESEN »

Fitness watches generate useful information, but increase patient anxiety

  Copenhagen, Denmark (August 4, 2020) — How does measuring our sleep, exercise and heart rates using various apps and fitness watches affect us? Self-quantifying may better the understanding of our individual health, but according to a new study, it also gives rise to anxiety. Is my heart beating slightly fast? Is a heart attack
WEITERLESEN »

A new device provides added protection against COVID-19 during endoscopic procedures

  Sendai, Japan (July 22, 2020) — The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection. However, a team of researchers has developed a simple, disposable, and inexpensive device to provide an additional barrier of protection for healthcare
WEITERLESEN »

81 million Americans lacking space or bathrooms to follow COVID quarantine recommendations

  Inadequate room for quarantine/isolation much more common among minorities hardest hit by pandemic, worsening spread within families   Chicago, IL, USA (July 21, 2020) — An article published today in the Annals of Internal Medicine reports that 25 million dwellings that house 81 million Americans lack adequate space or plumbing to allow compliance with
WEITERLESEN »

Front-line physicians stressed and anxious at work and home

  New study reports moderate to severe stress levels in ER doctors during the frenetic early phase of COVID-19 pandemic   San Francisco, CA, USA (July 21, 2020) — Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of
WEITERLESEN »

EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19 associated Cytokine Storm related hospital mortality by 65%

  Kilchberg, Switzerland (July 21, 2020) — Findings of a new study show that a widely available immunosuppressant used for treatment of rheumatic musculoskeletal diseases (RMDs) accelerates respiratory recovery, lowers hospital-mortality and reduces the likelihood of invasive mechanical ventilation compared to supportive care only. The Annals of the Rheumatic Diseases, ARD, the journal of the
WEITERLESEN »

Genetic markers are useful in predicting osteoporotic fracture risk

Findings hold potential for cost savings while improving efficiency of screening Boston, MA, USA (July 20, 2020) — A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda
WEITERLESEN »

“Love hormone” oxytocin could be used to treat cognitive disorders like Alzheimer’s

Scientists discover for the first time that oxytocin could be a potential new therapeutic option for cognitive disorders such as Alzheimer’s disease Tokyo, Japan (July 20, 2020) — Alzheimer’s disease is a progressive disorder in which the nerve cells (neurons) in a person’s brain and the connections among them degenerate slowly, causing severe memory loss,
WEITERLESEN »

Does having Alzheimer’s disease and dementia affect severity of delirium?

  New York, NY; USA (July 17, 2020) — Forms of dementia, including Alzheimer’s disease, gradually affect your cognitive function by harming your memory and your ability to think and make decisions. By 2050, experts project that 13.8 million older adults in the United States will develop Alzheimer’s disease and related Dementias (ADRD). Although Alzheimer’s
WEITERLESEN »

Study finds hidden emotions in the sound of words

ITHACA, N.Y., USA (July 14, 2020) – – In the midst of the COVID-19 crisis, it’s common to feel stress levels rise every time we hear the word “virus.” But new Cornell-led research reveals that the sound of the word itself was likely to raise your blood pressure – even before “corona” was added to
WEITERLESEN »

Cystic fibrosis: why so many respiratory complications?

  By demonstrating the key role of Vav3 protein, UNIGE researchers highlight how the protein Vav3 creates bacterial docking stations to facilitate lung infections in cystic fibrosis.   Geneva, Switzerland (July 13, 2020) — Cystic fibrosis, one of the most common genetic diseases in Switzerland, causes severe respiratory and digestive disorders. Despite considerable therapeutic advances,
WEITERLESEN »

Tocilizumab: Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators

  Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off ventilator within a month, despite double the risk of additional infection   Ann Arbor, MI, USA (July 13, 2020) — Critically ill COVID-19 patients who received a single dose of a drug that calms an
WEITERLESEN »

Dream on

  Study shows engaged workers should dare to daydream   St. Louis, MO, USA (July 13, 2020) —  A wandering, daydreaming mind can spur creativity … wait, where was I? Oh, yes, two researchers from Washington University in St. Louis and another from Pontificia Universidad Católica in Chile found that daydreaming carries significant creative benefits, especially
WEITERLESEN »

Age-related hearing loss in patients taking cognitive tests may result in misdiagnoses of dementia

  Leicestershire, UK (July 10, 2020) — The early and correct diagnosis of a cognitive impairment – such as dementia – is crucial as it allows interventions and treatments that may slow the progression of a patient’s symptoms to be quickly put in place. However, a new study by Loughborough University researcher Dr Christian Füllgrabe
WEITERLESEN »

About half of health care workers positive for COVID-19 by serology have no symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients. Nashville, Tennessee, USA (July 9, 2020) — Among 249 front-line health care workers who cared for COVID-19 patients during the first month of the pandemic in Tennessee, 8% tested positive for COVID-19 antibodies by serology testing,
WEITERLESEN »

Teva presents latest data on AJOVY® ▼ (fremanezumab) at EHF Congress

AMSTERDAM, NETHERLANDS (July 9, 2020) — Teva Pharmaceutical Europe B.V. has presented results from a pooled analysis of three randomized, double-blind, placebo-controlled Phase 3 studies assessing AJOVY® ▼ (fremanezumab), indicated for the preventative treatment of migraine in adults, which demonstrate clinically significant reductions in headache and migraine-related disability in the majority of patients studied. The
WEITERLESEN »

How fear transforms into anxiety

Study sheds new insight into the brain mechanisms at work Albuquerque, NM, USA (July 9, 2020) — A deadly coronavirus pandemic, economic instability and civil unrest menace the mental well-being of millions. Understanding how, in vulnerable people, fear from such frightening events evolves into lifelong anxiety, is critical for healing. A University of New Mexico
WEITERLESEN »

The best (and worst) materials for mask

    Tucson, Arizona, USA (July 8, 2020) — It’s intuitive and scientifically shown that wearing a face covering can help reduce the spread of the novel coronavirus that causes COVID-19. But not all masks are created equal, according to new University of Arizona-led research. Amanda Wilson, an environmental health sciences doctoral candidate in the
WEITERLESEN »

Therapy delivered electronically more effective than face to face

No difference in the level of satisfaction or function between the two methods of delivery Hamilton, ON, Canada (July 8, 2020) – Cognitive behavioural therapy delivered electronically to treat people with depression is more effective than face to face, suggests an evidence review led by McMaster University. Based on randomized control trials, the systematic review
WEITERLESEN »

COVID-19 brain complications found across the globe

Liverpool, UK (July 8, 2020) — Cases of brain complications linked to COVID-19 are occurring across the globe, a new review by University of Liverpool researchers has shown. Published in The Lancet Neurology, the study found that strokes, delirium and other neurological complications are reported from most countries where there have been large outbreaks of
WEITERLESEN »

Remdesivir can save more lives where ICUs are overwhelmed

  Boston, MA, USA (July 7, 2020) — Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity, such as South Africa, where COVID-19 is beginning
WEITERLESEN »

Novel biomarker discovery could lead to early diagnosis for deadly preeclampsia

The discovery of two new biomarkers has the potential to predict key underlying causes of preeclampsia and could lead to the early diagnosis Sydney, Australia (July 3, 2020) — Preeclampsia is a devastating disorder that occurs very suddenly in the second half of pregnancy and causes severe health problems for both mother and baby. Preeclampsia
WEITERLESEN »

Asthma and allergies more common in teens who stay up late

  Lausanne, Switzerland (July, 2020) — Teenagers who prefer to stay up late and wake later in the morning are more likely to suffer with asthma and allergies compared to those who sleep and wake earlier, according to a study published inERJ Open Research. [1] Asthma symptoms are known to be strongly linked to the
WEITERLESEN »

Why do more women have Alzheimer’s than men? It’s not just from living longer

Why do more women have Alzheimer’s than men? It’s not just from living longer MINNEAPOLIS, USA (June 24, 2020) — Middle-aged women are more likely than men to have changes in the brain related to Alzheimer’s disease, as detected by imaging, even when there are no differences in thinking and memory. This may be associated
WEITERLESEN »

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung